Start-ups set to drive disruption in global fertility markets

Start-ups have the potential to disrupt the fertility treatment market as innovation and ‘huge latent demand’ attract a surge in venture capital interest, according to analysis published today by London-based firm Octopus Ventures. The study found global venture capital investment in fertility-related start-ups increased nearly four-fold between 2014 and 2019 to reach $2.2bn. At the same…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »